TY - JOUR
T1 - A feasibility study of a personalised lifestyle programme (HealthForce) for individuals who have participated in cardiovascular risk screening
AU - Craigie, Angela M.
AU - Barton, Karen L.
AU - Macleod, Maureen
AU - Williams, Brian
AU - van Teijlingen, Edwin
AU - Belch, Jill J.F.
AU - Anderson, Annie S.
PY - 2011/5/1
Y1 - 2011/5/1
N2 - Objective: To assess the feasibility of a lifestyle intervention, focusing on diet and activity, in adults participating in cardiovascular screening. Methods: The 12-week lifestyle intervention comprised three personalised counselling sessions plus telephone contact. Outcome data were collected by anthropometry, activity monitoring and lifestyle questionnaires. Acceptability of study measures was assessed by questionnaire and the intervention delivery by in-depth interviews. Results: Between June 2008 and March 2009, 75 (62%) of 121 eligible individuals were recruited from Tayside, Scotland. Randomisation was to intervention (IV) (n= 55) or comparison group (CG) (n= 20). Retention was 99% across both groups. In the IV group, 63% increased moderate-vigorous activity by ≥ 30. minutes/week, 82% successfully maintained or lost weight (mean loss 1.1. kg, and 2.6. cm waist circumference) and 85% reported eating five portions of fruit and vegetables compared with 56% at baseline. No behaviour changes were detected in the CG. Feedback highlighted the value of lifestyle "checks," realising that current habits were sub-optimal, receiving personalised advice on specific behaviours, and feeling "healthier" through participation. Conclusions: HealthForce was feasible to deliver and implement, acceptable to participants, and associated with reported changes in health behaviours over a 12-week period. International Standard Randomised Controlled Trial Number: 38976321.
AB - Objective: To assess the feasibility of a lifestyle intervention, focusing on diet and activity, in adults participating in cardiovascular screening. Methods: The 12-week lifestyle intervention comprised three personalised counselling sessions plus telephone contact. Outcome data were collected by anthropometry, activity monitoring and lifestyle questionnaires. Acceptability of study measures was assessed by questionnaire and the intervention delivery by in-depth interviews. Results: Between June 2008 and March 2009, 75 (62%) of 121 eligible individuals were recruited from Tayside, Scotland. Randomisation was to intervention (IV) (n= 55) or comparison group (CG) (n= 20). Retention was 99% across both groups. In the IV group, 63% increased moderate-vigorous activity by ≥ 30. minutes/week, 82% successfully maintained or lost weight (mean loss 1.1. kg, and 2.6. cm waist circumference) and 85% reported eating five portions of fruit and vegetables compared with 56% at baseline. No behaviour changes were detected in the CG. Feedback highlighted the value of lifestyle "checks," realising that current habits were sub-optimal, receiving personalised advice on specific behaviours, and feeling "healthier" through participation. Conclusions: HealthForce was feasible to deliver and implement, acceptable to participants, and associated with reported changes in health behaviours over a 12-week period. International Standard Randomised Controlled Trial Number: 38976321.
KW - Cardiovascular screening
KW - Feasibility study
KW - Intervention
KW - Obesity
KW - Weight management
UR - http://www.scopus.com/inward/record.url?scp=79954594076&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79954594076&partnerID=8YFLogxK
U2 - 10.1016/j.ypmed.2011.03.010
DO - 10.1016/j.ypmed.2011.03.010
M3 - Article
C2 - 21419792
AN - SCOPUS:79954594076
SN - 0091-7435
VL - 52
SP - 387
EP - 389
JO - Preventive Medicine
JF - Preventive Medicine
IS - 5
ER -
